{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T12:05:35Z","timestamp":1779537935234,"version":"3.53.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T00:00:00Z","timestamp":1757462400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T00:00:00Z","timestamp":1757462400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Prince Sattam bin Abdulaziz University, Saudi Arabia","award":["PSAU\/2024\/03\/31934"],"award-info":[{"award-number":["PSAU\/2024\/03\/31934"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"DOI":"10.1007\/s11030-025-11339-8","type":"journal-article","created":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T13:34:12Z","timestamp":1757511252000},"page":"3977-3998","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Quantum chemical optimization and residue-specific stabilization of CDK20 inhibitors in hepatocellular carcinoma"],"prefix":"10.1007","volume":"30","author":[{"given":"Ahmed I.","family":"Foudah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed H.","family":"Alqarni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tariq M.","family":"Aljarba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talha","family":"Jawaid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osama A.","family":"Alkhamees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saud M.","family":"Alsanad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid I.","family":"AlHussaini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aftab","family":"Alam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,10]]},"reference":[{"key":"11339_CR1","doi-asserted-by":"publisher","unstructured":"Rawla P, Sunkara T, Muralidharan P, Raj JP (2018) Update in global trends and aetiology of hepatocellular carcinoma. Contemp Oncol 22:141\u2013150. https:\/\/doi.org\/10.5114\/wo.2018.78941","DOI":"10.5114\/wo.2018.78941"},{"issue":"3","key":"11339_CR2","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21763","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74(3):229\u2013263. https:\/\/doi.org\/10.3322\/caac.21763","journal-title":"CA Cancer J Clin"},{"key":"11339_CR3","doi-asserted-by":"publisher","unstructured":"Kim DY (2024) Changing etiology and epidemiology of hepatocellular carcinoma: Asia and worldwide. J Liver Cancer 24:62\u201370. https:\/\/doi.org\/10.17998\/jlc.2024.03.13","DOI":"10.17998\/jlc.2024.03.13"},{"issue":"2","key":"11339_CR4","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.jhep.2012.04.004","volume":"57","author":"European Association for the Study of the Liver","year":"2012","unstructured":"European Association for the Study of the Liver (2012) EASL clinical practical guidelines: management of alcoholic liver disease. J Hepatol 57(2):399\u2013420. https:\/\/doi.org\/10.1016\/j.jhep.2012.04.004","journal-title":"J Hepatol"},{"key":"11339_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jlr.2023.100430","author":"ME Rinella","year":"2024","unstructured":"Rinella ME, Sookoian S (2024) From NAFLD to MASLD: updated naming and diagnosis criteria for fatty liver disease. J Lipid Res. https:\/\/doi.org\/10.1016\/j.jlr.2023.100430","journal-title":"J Lipid Res"},{"issue":"2","key":"11339_CR6","doi-asserted-by":"publisher","first-page":"e54","DOI":"10.1016\/j.jhep.2023.10.029","volume":"80","author":"SJ Song","year":"2024","unstructured":"Song SJ, Lai JC-T, Wong GL-H, Wong VW-S, Yip TC-F (2024) Can we use old NAFLD data under the new MASLD definition? J Hepatol 80(2):e54\u2013e56. https:\/\/doi.org\/10.1016\/j.jhep.2023.10.029","journal-title":"J Hepatol"},{"issue":"2","key":"11339_CR7","doi-asserted-by":"publisher","first-page":"347","DOI":"10.21037\/hbsn-23-191","volume":"13","author":"G Testino","year":"2024","unstructured":"Testino G, Caputo F (2024) Alcohol-related liver disease. Hepatobiliary Surg Nutr 13(2):347. https:\/\/doi.org\/10.21037\/hbsn-23-191","journal-title":"Hepatobiliary Surg Nutr"},{"issue":"3","key":"11339_CR8","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1097\/hep.0000000000000000","volume":"81","author":"R Dhanasekaran","year":"2025","unstructured":"Dhanasekaran R, Suzuki H, Lemaitre L, Kubota N, Hoshida Y (2025) Molecular and immune landscape of hepatocellular carcinoma to guide therapeutic decision-making. Hepatology 81(3):1038\u20131057. https:\/\/doi.org\/10.1097\/hep.0000000000000000","journal-title":"Hepatology"},{"issue":"9","key":"11339_CR9","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/s10038-021-00928-6","volume":"66","author":"T Shibata","year":"2021","unstructured":"Shibata T (2021) Genomic landscape of hepatocarcinogenesis. J Hum Genet 66(9):845\u2013851. https:\/\/doi.org\/10.1038\/s10038-021-00928-6","journal-title":"J Hum Genet"},{"issue":"1","key":"11339_CR10","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s40169-019-0233-7","volume":"8","author":"TB Toh","year":"2019","unstructured":"Toh TB, Lim JJ, Chow EK-H (2019) Epigenetics of hepatocellular carcinoma. Clin Transl Med 8(1):13. https:\/\/doi.org\/10.1186\/s40169-019-0233-7","journal-title":"Clin Transl Med"},{"issue":"1","key":"11339_CR11","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s12072-022-10400-1","volume":"17","author":"YS Chang","year":"2023","unstructured":"Chang YS, Tu SJ, Chen HD, Hsu MH, Chen YC, Chao DS, Chung CC, Chou YP, Chang CM, Lee YT (2023) Integrated genomic analyses of hepatocellular carcinoma. Hepatol Int 17(1):97\u2013111. https:\/\/doi.org\/10.1007\/s12072-022-10400-1","journal-title":"Hepatol Int"},{"issue":"11","key":"11339_CR12","doi-asserted-by":"publisher","first-page":"2823","DOI":"10.1002\/1878-0261.13010","volume":"15","author":"C Ganini","year":"2021","unstructured":"Ganini C, Amelio I, Bertolo R, Bove P, Buonomo OC, Candi E, Cipriani C, Di Daniele N, Juhl H, Mauriello A (2021) Global mapping of cancers: the cancer genome atlas and beyond. Mol Oncol 15(11):2823\u20132840. https:\/\/doi.org\/10.1002\/1878-0261.13010","journal-title":"Mol Oncol"},{"issue":"3","key":"11339_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25031456","volume":"25","author":"R Becht","year":"2024","unstructured":"Becht R, Kie\u0142bowski K, Wasilewicz MP (2024) New opportunities in the systemic treatment of hepatocellular carcinoma\u2014today and tomorrow. Int J Mol Sci 25(3):1456. https:\/\/doi.org\/10.3390\/ijms25031456","journal-title":"Int J Mol Sci"},{"key":"11339_CR14","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s11938-021-00343-7","volume":"19","author":"TT Ghaziani","year":"2021","unstructured":"Ghaziani TT, Dhanasekaran R (2021) Recent progress in systemic therapy for hepatocellular cancer (HCC). Curr Treat Options Gastroenterol 19:351\u2013368. https:\/\/doi.org\/10.1007\/s11938-021-00343-7","journal-title":"Curr Treat Options Gastroenterol"},{"issue":"9","key":"11339_CR15","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.3390\/cancers15092506","volume":"15","author":"A Lazzaro","year":"2023","unstructured":"Lazzaro A, Hartshorn KL (2023) A comprehensive narrative review on the history, current landscape, and future directions of hepatocellular carcinoma (HCC) systemic therapy. Cancers (Basel) 15(9):2506. https:\/\/doi.org\/10.3390\/cancers15092506","journal-title":"Cancers (Basel)"},{"issue":"2","key":"11339_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25021259","volume":"25","author":"N Sadagopan","year":"2024","unstructured":"Sadagopan N, He AR (2024) Recent progress in systemic therapy for advanced hepatocellular carcinoma. Int J Mol Sci 25(2):1259. https:\/\/doi.org\/10.3390\/ijms25021259","journal-title":"Int J Mol Sci"},{"issue":"1","key":"11339_CR17","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1055\/s-0044-1779713","volume":"41","author":"II Selene","year":"2024","unstructured":"Selene II, Ozen M, Patel RA (2024) Hepatocellular carcinoma: advances in systemic therapy. Semin Intervent Radiol 41(1):56\u201362","journal-title":"Semin Intervent Radiol"},{"key":"11339_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40364-022-00359-7","volume":"10","author":"H Zhang","year":"2022","unstructured":"Zhang H, Zhang W, Jiang L, Chen Y (2022) Recent advances in systemic therapy for hepatocellular carcinoma. Biomark Res 10:1\u201321. https:\/\/doi.org\/10.1186\/s40364-022-00359-7","journal-title":"Biomark Res"},{"issue":"4","key":"11339_CR19","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1111\/apt.17851","volume":"59","author":"N Ben Khaled","year":"2025","unstructured":"Ben Khaled N, Zarka V, Hobeika B, Schneider J, Rau M, Weich A, Leicht HB, Ye L, Piseddu I, Dill MT (2025) Therapeutic sequences of systemic therapy after atezolizumab plus bevacizumab for hepatocellular carcinoma: real-world analysis of the IMMUreal cohort. Aliment Pharmacol Ther 59(4):587\u2013587. https:\/\/doi.org\/10.1111\/apt.17851","journal-title":"Aliment Pharmacol Ther"},{"issue":"20","key":"11339_CR20","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1056\/NEJMoa1915745","volume":"382","author":"RS Finn","year":"2020","unstructured":"Finn RS, Qin S, Ikeda M, Galle PR, Ducreux M, Kim T-Y, Kudo M, Breder V, Merle P, Kaseb AO (2020) Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma. N Engl J Med 382(20):1894\u20131905. https:\/\/doi.org\/10.1056\/NEJMoa1915745","journal-title":"N Engl J Med"},{"issue":"2","key":"11339_CR21","doi-asserted-by":"publisher","DOI":"10.1002\/cnr2.1464","volume":"5","author":"A Hiraoka","year":"2022","unstructured":"Hiraoka A, Kumada T, Tada T, Hirooka M, Kariyama K, Tani J, Atsukawa M, Takaguchi K, Itobayashi E, Fukunishi S (2022) Atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma: early clinical experience. Cancer Rep 5(2):e1464. https:\/\/doi.org\/10.1002\/cnr2.1464","journal-title":"Cancer Rep"},{"issue":"2","key":"11339_CR22","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1159\/000507767","volume":"9","author":"M Kudo","year":"2020","unstructured":"Kudo M (2020) A new era in systemic therapy for hepatocellular carcinoma: atezolizumab plus bevacizumab combination therapy. Liver Cancer 9(2):119\u2013137. https:\/\/doi.org\/10.1159\/000507767","journal-title":"Liver Cancer"},{"issue":"2","key":"11339_CR23","doi-asserted-by":"publisher","first-page":"278","DOI":"10.3390\/cancers17020278","volume":"17","author":"T Terashima","year":"2025","unstructured":"Terashima T, Kido H, Takata N, Hayashi T, Seki A, Nakagawa H, Nio K, Toyama T, Iida N, Yamada S (2025) Phase II study of atezolizumab and bevacizumab combination therapy for patients with advanced hepatocellular carcinoma previously treated with lenvatinib. Cancers 17(2):278. https:\/\/doi.org\/10.3390\/cancers17020278","journal-title":"Cancers"},{"issue":"1","key":"11339_CR24","doi-asserted-by":"publisher","first-page":"197","DOI":"10.3390\/cancers16010197","volume":"16","author":"I Ventura","year":"2023","unstructured":"Ventura I, Sanchiz L, Legidos-Garc\u00eda ME, Murillo-Llorente MT, P\u00e9rez-Bermejo M (2023) Atezolizumab and bevacizumab combination therapy in the treatment of advanced hepatocellular cancer. Cancers (Basel) 16(1):197. https:\/\/doi.org\/10.3390\/cancers16010197","journal-title":"Cancers (Basel)"},{"issue":"6","key":"11339_CR25","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1159\/000531626","volume":"12","author":"A Vogel","year":"2023","unstructured":"Vogel A, Finn RS, Blanchet Zumofen M-H, Heuser C, Sanchez Alvarez J, Leibfried M, Mitchell CR, Batson S, Redhead G, Gaillard VE (2023) Atezolizumab in combination with bevacizumab for the management of patients with hepatocellular carcinoma in the first-line setting: systematic literature review and meta-analysis. Liver Cancer 12(6):510\u2013520. https:\/\/doi.org\/10.1159\/000531626","journal-title":"Liver Cancer"},{"issue":"9","key":"11339_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30480-7","volume":"21","author":"X Yang","year":"2020","unstructured":"Yang X, Wang D, Lin J, Yang X, Zhao H (2020) Atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma. Lancet Oncol 21(9):e412. https:\/\/doi.org\/10.1016\/S1470-2045(20)30480-7","journal-title":"Lancet Oncol"},{"issue":"10","key":"11339_CR27","doi-asserted-by":"publisher","first-page":"790","DOI":"10.2174\/1389450123666230605091720","volume":"24","author":"S Chivukula","year":"2023","unstructured":"Chivukula S, Malkhed V (2023) The role of CDK20 protein in carcinogenesis. Curr Drug Targets 24(10):790\u2013796. https:\/\/doi.org\/10.2174\/1389450123666230605091720","journal-title":"Curr Drug Targets"},{"issue":"5","key":"11339_CR28","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1136\/gutjnl-2017-314549","volume":"67","author":"TF Greten","year":"2018","unstructured":"Greten TF, Korangy F (2018) CDK20 inhibition and immune checkpoint blockade: bringing cancer biology and tumour immunology together to develop novel treatment options for HCC. Gut 67(5):783\u2013784. https:\/\/doi.org\/10.1136\/gutjnl-2017-314549","journal-title":"Gut"},{"issue":"1","key":"11339_CR29","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s41392-024-01670-0","volume":"10","author":"J Zheng","year":"2025","unstructured":"Zheng J, Wang S, Xia L, Sun Z, Chan KM, Bernards R, Qin W, Chen J, Xia Q, Jin H (2025) Hepatocellular carcinoma: signaling pathways and therapeutic advances. Signal Transduct Target Ther 10(1):35. https:\/\/doi.org\/10.1038\/s41392-024-01670-0","journal-title":"Signal Transduct Target Ther"},{"issue":"6","key":"11339_CR30","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1039\/D3SC00561D","volume":"14","author":"F Ren","year":"2023","unstructured":"Ren F, Ding X, Zheng M, Korzinkin M, Cai X, Zhu W, Mantsyzov A, Aliper A, Aladinskiy V, Cao Z (2023) Alphafold accelerates artificial intelligence powered drug discovery: efficient discovery of a novel CDK20 small molecule inhibitor. Chem Sci 14(6):1443\u20131452. https:\/\/doi.org\/10.1039\/D3SC00561D","journal-title":"Chem Sci"},{"issue":"7873","key":"11339_CR31","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","volume":"596","author":"J Jumper","year":"2021","unstructured":"Jumper J, Evans R, Pritzel A, Green T, Figurnov M, Ronneberger O, Tunyasuvunakool K, Bates R, \u017d\u00eddek A, Potapenko A (2021) Highly accurate protein structure prediction with AlphaFold. Nature 596(7873):583\u2013589. https:\/\/doi.org\/10.1038\/s41586-021-03819-2","journal-title":"Nature"},{"issue":"D1","key":"11339_CR32","doi-asserted-by":"publisher","first-page":"D439","DOI":"10.1093\/nar\/gkab1061","volume":"50","author":"M Varadi","year":"2022","unstructured":"Varadi M, Anyango S, Deshpande M, Nair S, Natassia C, Yordanova G, Yuan D, Stroe O, Wood G, Laydon A (2022) AlphaFold protein structure database: massively expanding the structural coverage of protein-sequence space with high-accuracy models. Nucleic Acids Res 50(D1):D439\u2013D444. https:\/\/doi.org\/10.1093\/nar\/gkab1061","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"11339_CR33","doi-asserted-by":"publisher","first-page":"D368","DOI":"10.1093\/nar\/gkad888","volume":"52","author":"M Varadi","year":"2024","unstructured":"Varadi M, Bertoni D, Magana P, Paramval U, Pidruchna I, Radhakrishnan M, Tsenkov M, Nair S, Mirdita M, Yeo J (2024) Alphafold protein structure database in 2024: providing structure coverage for over 214 million protein sequences. Nucleic Acids Res 52(D1):D368\u2013D375. https:\/\/doi.org\/10.1093\/nar\/gkad888","journal-title":"Nucleic Acids Res"},{"key":"11339_CR34","doi-asserted-by":"crossref","unstructured":"Kim S, Bolton EE (2024) PubChem: a large\u2010scale public chemical database for drug discovery. In: Open Access Databases and Datasets for Drug Discovery, pp 39\u201366","DOI":"10.1002\/9783527830497.ch2"},{"issue":"D1","key":"11339_CR35","doi-asserted-by":"publisher","first-page":"D1516","DOI":"10.1093\/nar\/gkab1075","volume":"53","author":"S Kim","year":"2025","unstructured":"Kim S, Chen J, Cheng T, Gindulyte A, He J, He S, Li Q, Shoemaker BA, Thiessen PA, Yu B (2025) PubChem 2025 update. Nucleic Acids Res 53(D1):D1516\u2013D1525. https:\/\/doi.org\/10.1093\/nar\/gkab1075","journal-title":"Nucleic Acids Res"},{"issue":"13","key":"11339_CR36","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, Ferrin TE (2004) UCSF chimera\u2014a visualization system for exploratory research and analysis. J Comput Chem 25(13):1605\u20131612. https:\/\/doi.org\/10.1002\/jcc.20084","journal-title":"J Comput Chem"},{"issue":"W1","key":"11339_CR37","doi-asserted-by":"publisher","first-page":"W448","DOI":"10.1093\/nar\/gkv391","volume":"43","author":"CM Labb\u00e9","year":"2015","unstructured":"Labb\u00e9 CM, Rey J, Lagorce D, Vavru\u0161a M, Becot J, Sperandio O, Villoutreix BO, Tuff\u00e9ry P, Miteva MA (2015) MTiopenscreen: a web server for structure-based virtual screening. Nucleic Acids Res 43(W1):W448\u2013W454. https:\/\/doi.org\/10.1093\/nar\/gkv391","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"11339_CR38","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott O, Olson AJ (2010) Autodock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 31(2):455\u2013461. https:\/\/doi.org\/10.1002\/jcc.21334","journal-title":"J Comput Chem"},{"key":"11339_CR39","doi-asserted-by":"publisher","unstructured":"Xiong G, Wu Z, Yi J, Fu L, Yang Z, Hsieh C, Yin M, Zeng X, Wu C, Lu A et al (2021) ADMETlab 2.0: an integrated online platform for accurate and comprehensive predictions of ADMET properties. Nucleic Acids Res 49:W5\u2013W14. https:\/\/doi.org\/10.1093\/nar\/gkab255","DOI":"10.1093\/nar\/gkab255"},{"issue":"9","key":"11339_CR40","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1002\/jcc.26859","volume":"44","author":"K Hanasaki","year":"2023","unstructured":"Hanasaki K, Ali ZA, Choi M, Del Ben M, Wong BM (2023) Implementation of real-time TDDFT for periodic systems in the open-source PySCF software package. J Comput Chem 44(9):980\u2013987. https:\/\/doi.org\/10.1002\/jcc.26859","journal-title":"J Comput Chem"},{"issue":"1","key":"11339_CR41","doi-asserted-by":"publisher","DOI":"10.1002\/wcms.1340","volume":"8","author":"Q Sun","year":"2018","unstructured":"Sun Q, Berkelbach TC, Blunt NS, Booth GH, Guo S, Li Z, Liu J, McClain JD, Sayfutyarova ER, Sharma S (2018) Pyscf: the python-based simulations of chemistry framework. Wiley Interdiscip Rev Comput Mol Sci 8(1):e1340. https:\/\/doi.org\/10.1002\/wcms.1340","journal-title":"Wiley Interdiscip Rev Comput Mol Sci"},{"issue":"31.10","key":"11339_CR42","first-page":"5281","volume":"8","author":"G Landrum","year":"2013","unstructured":"Landrum G (2013) RDKit: a software suite for cheminformatics, computational chemistry, and predictive modeling. Greg Landrum 8(31.10):5281","journal-title":"Greg Landrum"},{"issue":"20","key":"11339_CR43","doi-asserted-by":"publisher","first-page":"6183","DOI":"10.1021\/acs.jcim.3c00729","volume":"63","author":"DA Case","year":"2023","unstructured":"Case DA, Aktulga HM, Belfon K, Cerutti DS, Cisneros GA, Cruzeiro VW, Forouzesh N, Giese TJ, G\u00f6tz AW, Gohlke H (2023) AmberTools. J Chem Inf Model 63(20):6183\u20136191. https:\/\/doi.org\/10.1021\/acs.jcim.3c00729","journal-title":"J Chem Inf Model"},{"key":"11339_CR44","doi-asserted-by":"publisher","DOI":"10.1063\/5.0000000","author":"J Janek","year":"2024","unstructured":"Janek J, Kolafa J (2024) Novel barostat implementation for molecular dynamics. J Chem Phys. https:\/\/doi.org\/10.1063\/5.0000000","journal-title":"J Chem Phys"},{"issue":"12","key":"11339_CR45","doi-asserted-by":"publisher","DOI":"10.1063\/1.4978807","volume":"146","author":"Y Lin","year":"2017","unstructured":"Lin Y, Pan D, Li J, Zhang L, Shao X (2017) Application of Berendsen barostat in dissipative particle dynamics for nonequilibrium dynamic simulation. J Chem Phys 146(12):124108. https:\/\/doi.org\/10.1063\/1.4978807","journal-title":"J Chem Phys"},{"issue":"12","key":"11339_CR46","doi-asserted-by":"publisher","first-page":"10089","DOI":"10.1063\/1.464397","volume":"98","author":"T Darden","year":"1993","unstructured":"Darden T, York D, Pedersen L (1993) Particle mesh Ewald: an N\u22c5log (N) method for Ewald sums in large systems. J Chem Phys 98(12):10089\u201310092. https:\/\/doi.org\/10.1063\/1.464397","journal-title":"J Chem Phys"},{"issue":"7","key":"11339_CR47","doi-asserted-by":"publisher","first-page":"3084","DOI":"10.1021\/ct400341p","volume":"9","author":"DR Roe","year":"2013","unstructured":"Roe DR, Cheatham TE III (2013) Ptraj and cpptraj: software for processing and analysis of molecular dynamics trajectory data. J Chem Theory Comput 9(7):3084\u20133095. https:\/\/doi.org\/10.1021\/ct400341p","journal-title":"J Chem Theory Comput"},{"issue":"9","key":"11339_CR48","doi-asserted-by":"publisher","first-page":"3314","DOI":"10.1021\/ct300418h","volume":"8","author":"BR Miller III","year":"2012","unstructured":"Miller BR III, McGee TD Jr, Swails JM, Homeyer N, Gohlke H, Roitberg AE (2012) MMPBSA.py: an efficient program for end-state free energy calculations. J Chem Theory Comput 8(9):3314\u20133321. https:\/\/doi.org\/10.1021\/ct300418h","journal-title":"J Chem Theory Comput"},{"issue":"21","key":"11339_CR49","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.1093\/bioinformatics\/btl461","volume":"22","author":"BJ Grant","year":"2006","unstructured":"Grant BJ, Rodrigues APC, ElSawy KM, McCammon JA, Caves LSD (2006) Bio3d: an R package for the comparative analysis of protein structures. Bioinformatics 22(21):2695\u20132696. https:\/\/doi.org\/10.1093\/bioinformatics\/btl461","journal-title":"Bioinformatics"},{"issue":"1","key":"11339_CR50","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1002\/pro.4076","volume":"30","author":"BJ Grant","year":"2021","unstructured":"Grant BJ, Skj\u00e6rven L, Yao X (2021) The bio3d packages for structural bioinformatics. Protein Sci 30(1):20\u201330. https:\/\/doi.org\/10.1002\/pro.4076","journal-title":"Protein Sci"},{"issue":"1","key":"11339_CR51","first-page":"82","volume":"40","author":"WL DeLano","year":"2002","unstructured":"DeLano WL (2002) PyMOL: an open-source molecular graphics tool CCP4. Newsl Protein Crystallogr 40(1):82\u201392","journal-title":"Newsl Protein Crystallogr"},{"key":"11339_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiolchem.2020.107322","volume":"87","author":"LP Kagami","year":"2020","unstructured":"Kagami LP, das Neves GM, Timmers LFS, Caceres RA, Eifler-Lima VL (2020) Geo-measures: a PyMOL plugin for protein structure ensembles analysis. Comput Biol Chem 87:107322. https:\/\/doi.org\/10.1016\/j.compbiolchem.2020.107322","journal-title":"Comput Biol Chem"},{"key":"11339_CR53","doi-asserted-by":"publisher","unstructured":"Zhao B-W, Su X-R, Yang Y, Li D-X, Li G-D, Hu P-W, Luo X, Hu LA (2024) Heterogeneous information network learning model with neighborhood-level structural representation for predicting lncRNA-miRNA interactions. Comput Struct Biotechnol J 23:2924\u20132933. https:\/\/doi.org\/10.1016\/j.csbj.2024.06.032","DOI":"10.1016\/j.csbj.2024.06.032"},{"key":"11339_CR54","doi-asserted-by":"publisher","unstructured":"Zhao B-W, Su X-R, Yang Y, Li D-X, Li G-D, Hu P-W, You Z-H, Luo X, Hu L (2025) Regulation-aware graph learning for drug repositioning over heterogeneous biological network. Inf Sci 686:121360. https:\/\/doi.org\/10.1016\/j.ins.2024.121360","DOI":"10.1016\/j.ins.2024.121360"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-025-11339-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-025-11339-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-025-11339-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T11:33:44Z","timestamp":1779536024000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11030-025-11339-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,10]]},"references-count":54,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["11339"],"URL":"https:\/\/doi.org\/10.1007\/s11030-025-11339-8","relation":{},"ISSN":["1573-501X"],"issn-type":[{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,10]]},"assertion":[{"value":"2 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}